MapLight Therapeutics Ownership | Who Owns MapLight Therapeutics?

MapLight Therapeutics Ownership Summary

MapLight Therapeutics is owned by 21.44% institutional investors, and 78.56% retail investors. Goldman sachs group is the largest institutional shareholder, holding 4.68% of MPLT shares.

MPLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MapLight Therapeutics	21.44%	-	78.56%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Biotech Stocks	384.56%	10.58%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Goldman sachs group	1.94M	4.68%	$34.03M
Blackrock funding, inc. /de	1.10M	2.64%	$19.24M
Nan fung group	971.25K	2.34%	$17.06M
Sanofi	912.04K	2.20%	$16.02M
Vanguard group	869.67K	2.10%	$15.28M
Pivotal bioventure partners investment advisor	611.45K	1.48%	$10.74M
Geode capital management	389.03K	0.94%	$6.83M
Blue owl capital lp	327.06K	0.79%	$5.74M
Marshall wace, llp	39.66K	0.10%	$696.81M
Td asset management	36.96K	0.09%	$649.20K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nan fung group	971.25K	15.27%	$17.06M
Sanofi	912.04K	5.16%	$16.02M
Pivotal bioventure partners investment advisor	611.45K	4.15%	$10.74M
Blue owl capital lp	327.06K	0.43%	$5.74M
Goldman sachs group	1.94M	0.00%	$34.03M
Metlife investment management	9.80K	0.00%	$172.10K
Ameritas investment partners	1.37K	0.00%	$24.08K
Marshall wace, llp	39.66K	0.00%	$696.81M
Walleye capital	11.69K	0.00%	$205.26M
Td asset management	36.96K	0.00%	$649.20K

Top Buyers

Holder	Shares	% Assets	Change
Goldman sachs group	1.94M	0.00%	1.94M
Blackrock funding, inc. /de	1.10M	0.00%	1.10M
Nan fung group	971.25K	15.27%	971.25K
Sanofi	912.04K	5.16%	912.04K
Vanguard group	869.67K	0.00%	869.67K

Top Sellers

Holder	Shares	% Assets	Change
Farther finance advisors	120.00	-	120.00
Citigroup	383.00	-	383.00
Federation des caisses desjardins du quebec	500.00	-	500.00
Amalgamated bank	530.00	0.00%	530.00
Sbi securities	607.00	0.00%	607.00

New Positions

Holder	Shares	% Assets	Change	Value
Goldman sachs group	1.94M	0.00%	1.94M	$34.03M
Blackrock funding, inc. /de	1.10M	0.00%	1.10M	$19.24M
Nan fung group	971.25K	15.27%	971.25K	$17.06M
Sanofi	912.04K	5.16%	912.04K	$16.02M
Vanguard group	869.67K	0.00%	869.67K	$15.28M

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	33	-	8,880,682	-	21	-	33	-	-	-

MPLT Ownership FAQ

Who Owns MapLight Therapeutics?

MapLight Therapeutics shareholders are primarily institutional investors at 21.44%, followed by 0% insiders and 0% retail investors. The average institutional ownership in MapLight Therapeutics's industry, Biotech Stocks , is 384.56%, which MapLight Therapeutics falls below.

Who owns the most shares of MapLight Therapeutics?

MapLight Therapeutics’s largest shareholders are Goldman sachs group (1.94M shares, 4.68%), Blackrock funding, inc. /de (1.1M shares, 2.64%), and Nan fung group (971.25K shares, 2.34%). Together, they hold 9.66% of MapLight Therapeutics’s total shares outstanding.

Does Blackrock own MapLight Therapeutics?

BlackRock is not among the top 10 institutional shareholders of MapLight Therapeutics.

Who is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.27% of its assets in 971.25K MapLight Therapeutics shares, valued at 17.06M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools